Year: 2022

Clean Motion has signed a four-year-long distribution agreement with X-Raam Srl. for the Italian market. The agreement refers to EVIG, Clean Motion’s new electric delivery vehicle. This means that X-Raam is responsible for sales, distribution, and aftermarket in Italy. The distributor’s sales forecast for next year is 200 vehicles, but it only commits to a volume of 50 vehicles. For the entire contract period, 2023-2026, they commit to 650 vehicles. The electric vehicle distributor X-Raam, with a dealer network in Italy, now has EVIG in its portfolio. X-Raam has a forecast of 200 vehicles as early as 2023 and has therefore signed a 4-year-long distribution agreement for EVIG. As part of this, X-Raam has committed to purchase at least 50 EVIG in 2023 and 600 EVIG in 2024–2026. Alberto Fiorini, General Manager at X-Raam, “Growth...

Visit avistacorp.com for latest environmental, social and governance (ESG) information SPOKANE, Wash., Dec. 09, 2022 (GLOBE NEWSWIRE) — Today, Avista (NYSE: AVA) published its latest Corporate Responsibility report and other environmental, social and governance (ESG) information on its corporate website, avistacorp.com. The content reports on Avista’s operations and includes commitments in four areas: environment, people, customers and communities, and ethical governance. The latest updates include Avista’s aspirational goals for workplace Equity, Inclusion and Diversity, an aspirational goal related to Supplier Diversity, and the publication of Avista’s current Equal Employment Opportunity (EEO) 2021 Employer Information Report EEO-1 Consolidated Report. The website also provides links to Avista’s continued reporting on a series...

IDEX Biometrics ASA held an extraordinary general meeting on 9 December 2022. 376.8 million shares or 34% of the capital was represented at the meeting. All resolutions were passed as proposed in the notice of the meeting. The general meeting resolved to issue the Tranche 2 shares of the private placement disclosed on 16 November 2022. 48,745,135 new shares will be issued at NOK 1.00 per share. Following the issue of the Tranche 2 shares, the company’s share capital is NOK 174,948,987.60 divided into 1,166,326.584 shares each with a nominal value of NOK 0.15. The minutes of the meeting will be available at the company’s web site, www.idexbiometrics.com, in due course. For further information contact:Marianne Bøe, Investor Relations E-mail: marianne.boe@idexbiometrics.comTel: + 47 9180 0186 About IDEX BiometricsIDEX Biometrics ASA (OSE:...

Conference Call Scheduled for December 15, 2022 at 11:00 am EASTERN DUBLIN, Ireland, Dec. 09, 2022 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2022 on Thursday, December 15, 2022. The Company has scheduled a conference call for that same day, December 15, 2022 at 11:00am ET (16:00pm GMT) to discuss the results of the quarter.Interested parties can access the call by dialing:US Toll Free: 1-844-861-5499International Toll: 1-412-317-6581Ireland Toll: 014311269Ireland Toll Free: 1800932830Please ask to be joined into the Trinity Biotech call.A simultaneous webcast of the call can be accessed at:https://event.choruscall.com/mediaframe/webcast.html?webcastid=XpdogyA1A...

Société anonyme au capital de 107 345 775,20 euros Siège social : 14, rue Royale, 75008 Paris 632 012 100 R.C.S. Paris Legal Entity Identifyer : 529900JI1GG6F7RKVI53   Disclosure of total number of voting rights and number of shares in the capital at 30 November 2022     Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF’s General Regulations:Total number of shares 536,729,433Number of real voting rights (excluding treasury shares) 535,186,562Theoretical number of voting rights (including treasury shares*) (*) pursuant to article 223-11 of the AMF’s General Regulations 536,729,433    About L’Oréal For over 110 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our...

Company announcement no 32/2022 In accordance with Article 19 (3) of the Market Abuse Regulation, Columbus A/S is required to disclose information regarding trading in Columbus A/S shares and/or related securities by persons discharging managerial responsibilities in Columbus A/S and/or persons closely associated with them. Please see the attached document for transaction details reported to Columbus. Ib Kunøe                        Søren Krogh KnudsenChairman of the Board                CEO & PresidentFor further information, please contact: CEO & President, Søren Krogh Knudsen, +45 70 20 50 00AttachmentNotification of transactions Consolidated Holdings AS 081222 PDF